Angiotensin Receptor Blockers
Showing 1 - 25 of 9,166
Angiotensin Converting Enzyme Inhibitors and Angiotensin
Not yet recruiting
- COVID-19 Pneumonia
- Covid_19
- (no location specified)
Jun 5, 2022
Aortic Stenosis Trial in Québec, Odense (Angiotensin Receptor Blockers, Placebo)
Recruiting
- Aortic Stenosis
- Angiotensin Receptor Blockers
- Placebo
-
Québec, Quebec, Canada
- +1 more
Mar 28, 2022
The Effect of RAAS Blockers on ACE2 Levels
Completed
- Renin-Angiotensin System
- ACE inhibitor ,angiotensin receptor blockers
-
Cairo, Select A State Or Province, EgyptAinshams University
Jun 10, 2022
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li,MD
Apr 18, 2023
Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor Trial in San Francisco (Continuation of ACEi
Active, not recruiting
- Chronic Kidney Disease
- +3 more
- Continuation of ACEi and/or ARBs
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 4, 2021
Coronavirus Disease 2019, COVID-19 Trial in Australia, India (Angiotensin Receptor Blockers, Placebo)
Completed
- Coronavirus Disease 2019
- COVID-19
- Angiotensin Receptor Blockers
- Placebo
-
Camperdown, New South Wales, Australia
- +21 more
Mar 2, 2022
Surgery, Angiotensin Hypertension, Perioperative Complication Trial in Netherlands (drug, diagnostic test, behavioral)
Recruiting
- Surgery
- +2 more
- Perioperative withdrawal of angiotensin converting enzyme inhibitors and angiotenin receptor blockers
- +4 more
-
Amsterdam, Netherlands
- +6 more
Jan 6, 2022
Oxidative Stress Trial in Guadalajara (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers)
Completed
- Oxidative Stress
- Angiotensin converting enzyme inhibitor
- Angiotensin Receptor Blockers
-
Guadalajara, Jalisco, MexicoEnrique Rojas Campos
Feb 8, 2022
Hypertension, COVID-19 Trial in Kiev (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers, Direct renin
Completed
- Hypertension
- COVID-19
- Angiotensin converting enzyme inhibitor
- +2 more
-
Kiev, Please Select, UkraineMedical Practice Prof D.Ivanov
Feb 16, 2022
Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers
Recruiting
- Cognitively Normal Older Adults
- +3 more
- Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
- PCP
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 1, 2022
STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial (Dapagliflozin 10Mg Tab, Placebo)
Not yet recruiting
- STEMI - ST Elevation Myocardial Infarction
- Left Ventricular Systolic Dysfunction
- Dapagliflozin 10Mg Tab
- Placebo
- (no location specified)
Sep 6, 2021
Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)
Recruiting
- Kidney Disease
- Bremelanotide
- RAAS inhibition therapy
-
Chula Vista, California
- +5 more
Jan 23, 2023
Breast Cancer, Tumor, Breast, Breast Diseases Trial in Poland (Sacubitril-valsartan)
Not yet recruiting
- Breast Cancer
- +12 more
-
Opole, Opolskie, Poland
- +3 more
Jul 15, 2022
COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II
Recruiting
- COVID-19
- Cardiovascular Diseases
- Angiotensin converting enzyme inhibitor
- Angiotensin II Receptor Blockers
-
Maceio, Alagoas, Brazil
- +30 more
Jan 13, 2023
Chronic Kidney Disease (CKD) Trial in Germany, United States (LHW090, Placebo)
Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2
Recruiting
- Diabetes Mellitus
- Cardiovascular Diseases
- Renin-angiotensin-aldosterone system inhibitors
- +2 more
-
Singapore, SingaporeSingapore General Hospital (SGH)
Apr 28, 2021
ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and
Completed
- COVID-19
-
Pozzilli, ItalyIRCCS Neuromed, Department of Epidemiology and Prevention
Sep 14, 2020
Prostate Tumor Trial in Seoul (remimazolam, Propofol)
Not yet recruiting
- Prostate Tumor
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Oct 19, 2023
Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors
Not yet recruiting
- Aortic Valve Stenosis
- Angiotensin Receptor-Neprilysin Inhibitor
- antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 4, 2023
Pathophysiologic Hemodynamics After Primary Unilateral Total Hip
Recruiting
- Orthostatic Intolerance
- Orthostatic Hypotension
- Mobilisation procedure
-
Copenhagen, DenmarkHvidovre University Hospital
Apr 8, 2021
Heart Failure Trial in Worldwide (OPTIMIZER, Optimal medical therapy)
Terminated
- Heart Failure
- OPTIMIZER
- Optimal medical therapy
-
Graz, Austria
- +7 more
Sep 1, 2020
Sleep Disordered Breathing, Hypoxia, Respiration; Sleep Disorder Trial in Kelowna (Hyperoxic Hypercapnic Ventilatory Response
Completed
- Sleep Disordered Breathing
- +3 more
- Hyperoxic Hypercapnic Ventilatory Response Test
- +5 more
-
Kelowna, British Columbia, CanadaUniversity of British Columbia
Sep 2, 2020
Hypertension Trial in Thessaloniki, London (Anti-hypertensive Medication -)
Completed
- Hypertension
- Anti-hypertensive Medication -
-
Thessaloniki, Greece
- +1 more
Mar 5, 2021
COVID-19 Trial in Philadelphia (Discontinuation of ARB/ACEI, Continuation of ARB/ACEI)
Completed
- COVID-19
- Discontinuation of ARB/ACEI
- Continuation of ARB/ACEI
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Health System
Apr 7, 2021